Portal Instruments is developing a unique platform technology to transform the delivery of modern medicines and improve the patient experience. Portal's patented technology enables the precise delivery of the exact amount of drug at the desired tissue depth irrespective of drug viscosity and composition; particularly important for today's new biological drugs. The company's delivery mechanism is silent, painless, and highly customizable across a large variety of medical, animal, agricultural, and cosmetic applications.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/15/14 | $11,000,000 | Series A |
PBJ Capital Sanofi | undisclosed |
